May 2017 - Moleculomics

NC3Rs CRACK IT Solution: Cross-species comparative in silico platform (CRISP)

By Will Krawszik | May 26, 2017 | Collaborations | Like |

Moleculomics has gained the support of the NC3Rs through the development of a CRACK IT Solution; A technology partnering hub to accelerate the translation of technologies with 3Rs potential (‘Solutions’) by helping to identify new partners and customers to use, develop and validate the technology. As such, a collaborative opportunity is presented to help validate their CRISP comparative in silico structural/ functional platform that identifies species differences in liver activity,

In silico drug discovery software platform for the UK Ministry of Defence

By Will Krawszik | May 7, 2017 | News | Like |

A spin out company of the Institute of Life Science at Swansea University has recently delivered an in silico drug discovery software platform for the UK Ministry of Defence.

The software tool named TargetPath, developed for the identification of protein antibiotic or anti-bacterial target(s) within a pathogen, will be used by the scientists of Defence,

Spin-out company helps get effective drugs to market, more quickly and cheaply

By Will Krawszik | May 7, 2017 | News | Like |

Getting better drugs to market faster, and at a fraction of the cost, is a step closer thanks to technology for speeding up the testing process, which is being developed by a Swansea University spin-out company, Moleculomics.

The company has been developing comprehensive platforms of computer-generated models for protein structures in the human body.

START TYPING AND PRESS ENTER TO SEARCH